Anticancer composition

Details Anticancer composition Anticancer composition

2007-01-16

2007-01-16

Wax, Robert A. (Department: 1653)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S362000

Reexamination Certificate

active

10508268

ABSTRACT:
The present invention relates to an anticancer composition comprising a therapeutically effective amount of one or more active components selected from the group consisting of citric acid; citric acid and zinc; citric acid and albumin; and citric acid, zinc and albumin, and a pharmaceutically acceptable carrier. The anticancer composition of the present invention has strong anticancer activity, and in addition does not have harmful side effects.

REFERENCES:
patent: 4191749 (1980-03-01), Bryant
patent: 6133317 (2000-10-01), Hart
patent: 01/85178 (2001-11-01), None
patent: WO 01/85178 (2001-11-01), None
Kavanagh et al., Prostate, 1994, 24(3): 139-142.
Sorensen et al., Molecular Human Reproduction, 1999, 5(4): 331-337.
Therien et al., Biology of Reproduction, 1999, 61: 590-598.
Jain et al., Barriers to Drug Delivery in Solid Tumors, Scientific American, Jul. 1994, pp. 58-65.
Amano et al., “Fluorescence Spectra From Human Semen And Their Relationship With Sperm Parameters,” Archives of Andrology 36:9-15 (1996).
Costello et al., “The Intermediary Metabolism of the Prostate: A Key to Understanding the Pathogenesis and□□Progression of Prostate Malignancy,” Oncology 2000; 59:269-282□□.

Affiliated with

Also associated with

Rating

Anticancer composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anticancer composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anticancer composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3768294